In The News Posted July 2, 2019 Share Posted July 2, 2019 NEW YORK, July 2, 2019 /PRNewswire/ -- A2A Pharmaceuticals Inc. (A2A), a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents, today announced the appointment of Dr. Sotirios G. Stergiopoulos as President and Chief Executive... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.